View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
April 9, 2020

AstraZeneca, GSK and partner to establish Covid-19 testing laboratory

Novacyt is set to collaborate with AstraZeneca, GSK and the University of Cambridge to establish a new testing laboratory as part of the UK Government's five-pillar plan to expedite testing for coronavirus (Covid-19).

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

F ollow the latest updates of the outbreak on our timeline.

Novacyt is set to collaborate with AstraZeneca, G SK and the University of Cambridge to establish a new testing laboratory as part of the UK G overnment’s five-pillar plan to expedite testing for coronavirus (Covid-19).

The laboratory will be set up at the university’s Anne McLaren laboratory. It will be used for high-throughput screening for Covid-19 testing and the analysis of alternative chemical reagent use for test kits to mitigate supply shortages.

Novacyt will provide its Covid-19 test to generate results data and ensure an effective workflow process within the facility for the testing.

The company’s molecular diagnostics division Primerdesign developed the Covid-19 polymerase chain reaction (PCR) test.

Novacyt CEO G raham Mullis said: “In the UK, we continue to work with the NHS and Public Health Engl and to supply our Covid-19 test to a growing number of hospitals and, through this new collaboration with AstraZeneca, G SK and the University of Cambridge, we are very pleased to further assist the government to increase testing.

“I, again, want to extend my gratitude to Novacyt employees who are working all hours and to our supply chain for their continued support, as all stakeholders work together during this difficult time.”

In F ebruary, Novacyt approached the US F ood and Drug Administration (F DA) for the emergency use approval (EUA) of its novel coronavirus test. The company has also been in discussion with several NHS hospitals and Public Health Engl and on the nCoV test.

Meanwhile, AstraZeneca and G SK are also working together to support the UK national testing centres in Milton Keynes, Alderley Park and G lasgow by providing process optimisation for Covid-19.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network